175 related articles for article (PubMed ID: 25152223)
1. Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases.
Langsenlehner U; Hofmann G; Renner W; Gerger A; Krenn-Pilko S; Thurner EM; Krippl P; Langsenlehner T
Acta Oncol; 2015 Mar; 54(3):368-76. PubMed ID: 25152223
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.
Langsenlehner T; Thurner EM; Renner W; Gerger A; Kapp KS; Langsenlehner U
Strahlenther Onkol; 2014 Apr; 190(4):364-9. PubMed ID: 24435801
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.
Sa-Nguanraksa D; Chuangsuwanich T; Pongpruttipan T; Kummalue T; Rojananin S; Ratanawichhitrasin A; Prasarttong-Osoth P; Chuthatisith S; Pisarnturakit P; Aeumrithaicharoenchok W; Rushatamukayanunt P; Lohsiriwat V; Boonsripitayanon M; Malasit P; O-Charoenrat P
Mol Med Rep; 2013 Oct; 8(4):1242-50. PubMed ID: 23904001
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
[TBL] [Abstract][Full Text] [Related]
8. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
10. Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.
Langsenlehner T; Renner W; Gerger A; Hofmann G; Thurner EM; Kapp KS; Langsenlehner U
Strahlenther Onkol; 2011 Dec; 187(12):784-91. PubMed ID: 22105769
[TBL] [Abstract][Full Text] [Related]
11. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.
Supic G; Jovic N; Zeljic K; Kozomara R; Magic Z
Oral Oncol; 2012 Nov; 48(11):1171-7. PubMed ID: 22818823
[TBL] [Abstract][Full Text] [Related]
12. Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Schneider BP; Wang M; Radovich M; Sledge GW; Badve S; Thor A; Flockhart DA; Hancock B; Davidson N; Gralow J; Dickler M; Perez EA; Cobleigh M; Shenkier T; Edgerton S; Miller KD;
J Clin Oncol; 2008 Oct; 26(28):4672-8. PubMed ID: 18824714
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.
Lee SJ; Lee SY; Jeon HS; Park SH; Jang JS; Lee GY; Son JW; Kim CH; Lee WK; Kam S; Park RW; Park TI; Kang YM; Kim IS; Jung TH; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):571-5. PubMed ID: 15767331
[TBL] [Abstract][Full Text] [Related]
14. The Association Between VEGF +936C/T and -634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects.
Ma J; Hu W; Zhang P; Sun Y; Wang N; Teng X; Qiao Q
Cancer Invest; 2015; 33(7):312-7. PubMed ID: 26067906
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.
Arduino PG; Menegatti E; Scoletta M; Battaglio C; Mozzati M; Chiecchio A; Berardi D; Vandone AM; Donadio M; Gandolfo S; Scully C; Broccoletti R
J Oral Pathol Med; 2011 Jul; 40(6):510-5. PubMed ID: 21251073
[TBL] [Abstract][Full Text] [Related]
16. Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population.
Kim T-; Hong JM; Lee J-; Oh B; Park EK; Lee C-; Bae S-; Kim S-
Osteoarthritis Cartilage; 2008 Mar; 16(3):287-91. PubMed ID: 17698375
[TBL] [Abstract][Full Text] [Related]
17. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer.
Sa-Nguanraksa D; Kooptiwut S; Chuangsuwanich T; Pongpruttipan T; Malasit P; O-Charoenrat P
Mol Med Rep; 2014 Mar; 9(3):1044-8. PubMed ID: 24401996
[TBL] [Abstract][Full Text] [Related]
19. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel.
Koutras AK; Kotoula V; Papadimitriou C; Dionysopoulos D; Zagouri F; Kalofonos HP; Kourea HP; Skarlos DV; Samantas E; Papadopoulou K; Kosmidis P; Pectasides D; Fountzilas G
Pharmacogenomics J; 2014 Jun; 14(3):248-55. PubMed ID: 24061601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
